Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST003984)

(Analysis AN006560)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14	F15	F16	F17	F18	F19	F20
Asp	ME1051426	0.72	1.00	0.61	0.69	0.80	1.39	1.15	0.77	1.20	10.11	0.52	0.55	NA	0.57	NA	0.96	0.55	0.90	0.54	3.67
Glu	ME1051429	0.69	0.94	0.61	0.74	0.55	1.28	0.92	0.88	1.60	6.91	0.51	0.93	0.36	0.97	NA	0.98	0.67	0.97	0.51	3.10
Spermine	ME1051420	0.86	1.10	0.68	0.58	0.35	1.45	1.20	0.71	1.33	2.21	NA	0.35	NA	0.40	NA	0.34	0.47	3.47	NA	2.08
Serotonin	ME1051418	NA	0.35	NA	0.88	NA	0.39	1.18	NA	NA	0.33	0.81	0.82	NA	0.76	NA	1.00	0.68	1.67	1.53	1.40
Spermidine	ME1051419	1.19	1.38	0.67	0.86	0.58	3.26	1.83	0.89	2.08	2.67	0.57	0.60	0.59	0.58	NA	0.64	0.63	0.97	0.57	1.42
alpha-AAA	ME1051404	0.97	0.98	0.73	1.21	0.96	0.96	1.06	0.95	0.97	1.03	NA	0.84	0.96	1.21	NA	NA	0.96	0.86	0.81	NA
Kynurenine	ME1051411	0.99	0.92	0.77	0.91	0.79	0.90	1.10	0.96	1.19	3.94	1.04	1.06	1.32	0.91	0.93	0.83	1.07	0.91	0.82	0.90
Phe	ME1051437	1.08	0.89	0.93	0.91	1.37	1.06	0.99	0.99	1.05	3.71	1.04	0.93	1.27	0.86	1.23	0.84	0.96	1.00	0.94	1.41
Orn	ME1051436	0.61	0.69	0.68	0.75	0.49	0.92	0.61	0.74	0.41	0.78	1.18	1.28	1.15	1.23	0.62	1.58	1.27	1.22	0.85	1.67
Ile	ME1051432	0.94	0.85	0.91	0.92	1.56	1.21	1.01	0.97	1.12	1.74	0.91	0.86	1.97	0.89	1.78	0.96	0.99	1.10	1.25	1.23
Leu	ME1051433	1.00	0.87	1.19	0.83	1.78	1.31	0.87	1.04	1.22	1.03	0.91	0.93	1.83	0.91	1.87	0.95	1.02	1.02	1.18	1.19
Taurine	ME1051422	0.82	0.99	0.78	0.87	1.16	1.20	1.03	0.97	1.25	1.29	1.08	0.98	0.88	0.87	1.24	1.17	1.05	1.00	1.01	1.41
Arg	ME1051424	1.18	1.27	1.25	1.26	1.14	1.66	1.08	1.26	1.07	1.17	0.73	0.81	0.74	0.82	0.77	0.88	0.61	0.88	0.77	1.03
Thr	ME1051440	0.91	1.09	1.01	1.15	0.95	1.54	0.91	1.10	0.87	0.79	0.81	0.99	0.84	1.03	0.79	1.20	0.82	0.94	0.66	1.03
His	ME1051431	1.13	1.08	1.12	1.07	1.23	1.20	1.05	1.09	1.06	0.88	0.95	0.94	0.96	0.91	0.94	0.86	0.96	0.91	0.86	1.01
Lys	ME1051434	1.12	1.11	1.24	1.05	1.14	1.26	0.96	1.15	0.92	0.94	0.83	0.97	0.92	0.95	0.76	0.93	0.92	0.94	0.71	1.09
Ser	ME1051439	1.07	1.05	1.16	1.07	1.00	1.22	0.92	1.13	0.88	0.92	0.90	0.98	0.89	0.97	0.91	0.92	0.92	0.99	0.77	1.20
Gln	ME1051428	1.10	1.14	1.03	1.21	1.12	1.31	1.02	1.11	0.97	1.08	0.85	0.94	0.95	0.95	0.82	0.90	0.90	0.90	0.84	0.70
Asn	ME1051425	1.06	1.08	1.11	1.10	1.24	1.39	0.92	1.13	1.07	1.35	0.93	0.94	0.85	0.93	0.91	0.94	0.86	0.92	0.76	1.07
Creatinine	ME1051407	1.11	1.07	1.25	1.09	1.13	1.20	1.04	1.00	1.06	1.34	0.92	0.91	0.89	0.99	0.85	0.82	1.09	0.89	0.87	0.87
Tyr	ME1051442	0.96	0.99	0.97	0.97	1.14	1.19	0.99	1.03	0.97	3.08	0.84	0.96	1.37	0.92	1.10	0.88	0.93	1.04	0.89	1.00
Val	ME1051443	0.95	0.87	0.97	0.95	1.43	1.14	1.01	0.97	1.09	2.63	0.92	0.92	1.71	0.91	1.55	0.91	0.96	1.06	1.12	1.17
Trp	ME1051441	0.94	0.83	0.76	0.82	0.92	0.85	0.84	0.81	0.82	2.04	1.24	1.23	1.30	0.95	1.23	0.86	1.10	1.12	0.86	1.39
ADMA	ME1051403	1.09	1.10	1.20	1.08	1.15	1.42	1.00	1.14	1.10	1.98	0.87	0.90	0.85	0.93	0.73	0.95	0.94	0.83	0.77	0.91
SDMA	ME1051417	1.11	1.02	1.21	1.00	1.22	1.13	1.12	0.97	1.09	1.80	0.93	0.93	1.00	0.91	0.88	0.97	1.09	0.89	0.95	0.94
Cit	ME1051427	1.05	1.01	1.18	0.98	0.83	1.31	0.88	1.02	0.84	2.22	1.10	1.02	0.83	1.02	0.64	1.12	0.93	0.88	0.88	0.83
Gly	ME1051430	1.25	1.03	1.25	1.03	1.11	1.30	0.91	1.19	0.92	2.51	0.96	0.88	0.89	0.91	0.97	0.89	0.83	0.97	0.73	1.02
Ala	ME1051423	0.88	1.05	0.88	1.00	0.97	1.32	0.94	1.01	0.88	2.42	0.95	1.03	0.94	0.91	0.85	1.07	0.94	0.97	0.71	1.21
Sarcosine	ME1051416	0.88	1.04	0.92	0.98	0.99	1.28	0.91	1.02	0.89	2.44	0.96	1.03	0.90	0.93	0.87	1.09	0.95	0.97	0.72	1.19
Met	ME1051435	1.01	1.07	1.06	0.99	1.18	1.18	0.96	1.01	0.88	2.39	0.86	1.02	1.23	0.93	1.31	0.85	0.90	0.97	0.78	1.00
Pro	ME1051438	1.02	0.97	1.06	1.08	1.07	1.43	0.90	0.97	0.81	1.82	0.99	0.97	1.24	0.99	1.11	1.06	0.86	0.99	0.77	1.15

Factors:

F1	Sample source:Peritoneal fluid \| Group:Control \| Stage:C \| Cycle phase:Luteal
F2	Sample source:Peritoneal fluid \| Group:Control \| Stage:C \| Cycle phase:Proliferative
F3	Sample source:Peritoneal fluid \| Group:Endometriosis \| Stage:I \| Cycle phase:Luteal
F4	Sample source:Peritoneal fluid \| Group:Endometriosis \| Stage:I \| Cycle phase:Proliferative
F5	Sample source:Peritoneal fluid \| Group:Endometriosis \| Stage:II \| Cycle phase:Luteal
F6	Sample source:Peritoneal fluid \| Group:Endometriosis \| Stage:II \| Cycle phase:Proliferative
F7	Sample source:Peritoneal fluid \| Group:Endometriosis \| Stage:III \| Cycle phase:Luteal
F8	Sample source:Peritoneal fluid \| Group:Endometriosis \| Stage:III \| Cycle phase:Proliferative
F9	Sample source:Peritoneal fluid \| Group:Endometriosis \| Stage:IV \| Cycle phase:Luteal
F10	Sample source:Peritoneal fluid \| Group:Endometriosis \| Stage:IV \| Cycle phase:Proliferative
F11	Sample source:Plasma \| Group:Control \| Stage:C \| Cycle phase:Luteal
F12	Sample source:Plasma \| Group:Control \| Stage:C \| Cycle phase:Proliferative
F13	Sample source:Plasma \| Group:Endometriosis \| Stage:I \| Cycle phase:Luteal
F14	Sample source:Plasma \| Group:Endometriosis \| Stage:I \| Cycle phase:Proliferative
F15	Sample source:Plasma \| Group:Endometriosis \| Stage:II \| Cycle phase:Luteal
F16	Sample source:Plasma \| Group:Endometriosis \| Stage:II \| Cycle phase:Proliferative
F17	Sample source:Plasma \| Group:Endometriosis \| Stage:III \| Cycle phase:Luteal
F18	Sample source:Plasma \| Group:Endometriosis \| Stage:III \| Cycle phase:Proliferative
F19	Sample source:Plasma \| Group:Endometriosis \| Stage:IV \| Cycle phase:Luteal
F20	Sample source:Plasma \| Group:Endometriosis \| Stage:IV \| Cycle phase:Proliferative

Data matrix